73079-075 : Zokinvy 75 mg Oral Capsule
NDC: | 73079-075 |
Labeler: | Eiger Biopharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Zokinvy |
Dosage Form: | Oral Capsule |
Application #: | NDA213969 |
Rev. Date: |
NDC Package Codes:
- 73079-075-30: 1 BOTTLE, PLASTIC IN 1 CARTON (73079‑075‑30) > 30 CAPSULE IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Lonafarnib
Dosage Strength:
- 75 mg
Pharmaceutical Classes:
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 2C19 Inhibitors [MoA]
- Cytochrome P450 2C8 Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Farnesyltransferase Inhibitor [EPC]
- Farnesyltransferase Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 73079-050 Zokinvy 50 mg Oral Capsule by Eiger Biopharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 73079-050Next: 73080-100 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.